分析测试百科网 > 行业资讯 > 焦点事件

2014中国（南京）国际生物医药产业博览会部分海外企业预览

2014.4.11

　　GREATER GENEVA BERNE area (GGBa)

　　GREATER GENEVA BERNE area (GGBa) is an Economic Development Agency complementary to BioAlps ‘s mission offering tailored-made solutions to the Biotech and Medtech industries wishing to develop activities in Western Switzerland

　　provides expert insight into the region’s different cultural and economic strengths and all the information needed by an enterprise to be a success in Switzerland.

　　offers time-saving support to international companies

　　brings company ideas to the market by finding industrial partners and helping negotiation with them

　　provide free, tailor-made assistance in all stages of the process, from evaluating suitable locations to finalizing

　　identifies suitable premises close to potential industrial/technological partners in Biotech and Medtech sectors

　　provides investment opportunities for small and medium-sized enterprises (SME) and start-up businesses

　　establishes networking opportunities for biotech and medtech industries facilitating their integration

　　BiowebSpin

　　Bio Dashboard is the place to get information, exchange, work, and promote online worldwide in Life Sciences for researchers, executives, business developers, marketers, media, students, etc.

　　Beyond a social network, Biowebspin offers unique adapted tools to Pharma, Biotech, and Medtech professionals in order to optimize and simplify their daily tasks at work.

　　Engagement: Biowebspin helps associations, guilds, valorization organizations, and professionals or future professionals around the world who have the will to promote Biosciences and help its actors. Special offers or partnerships would be offered.

　　Debiopharm

　　Debiopharm International SA searches, evaluates and in-licenses promising drug candidates for development. Towards the end of the development process, the products are licensed out to pharmaceutical companies for world-wide marketing and sales.

　　The Company has successfully developed five products. These products include:

　　Eloxatin® for the treatment of colorectal cancer,

　　Decapeptyl®/Trelstar®/Pamorelin®/1-month, 3-month and 6-month formulations for the treatment of advanced prostate cancer, endometriosis, precocious puberty, in vitro fertilisation programmes, uterine fibroids, and

　　Moapar®/Salvacyl® for the treatment of severe sexual deviations.

　　Lyncée Tec

　　In life science applications, DHM-T1000 provides precise Quantitative Phase Measurements (QPM) of living cell cultures up to confluence, without the use of any contrast agent and with very low illumination power. It is very sensitive to small morphology modifications, and to intra-cellular concentration changes. The DHM-T1000 is thus an ideal instrument for high-throughput screening, time lapse measurements and time monitoring. Used in conjunction with the optional fluorescence module, it enables simultaneous DHM and fluorescence measurements.

　　Phasis

　　Bionano Gold coated glass slides: Gold thin films grown on microscope glass slides with Titanium adhesion layer.

　　Au(111) thin films on mica: Gold (111) epitaxial thin films grown on freshly cleaved mica substrates

　　R&D within PHASIS: PHASIS is involved in several applied research projects with both academic and industrial partners. PHASIS is interested in the use of new materials to bring new insights in the field of gas sensors. Moreover, the flexibility of PHASIS' equipment allows the production of thin films with tailored properties.

　　regenHU

　　3D Bio-Printers:

　　3D cellular constructs on-demand Bottom-up fabrication of scaffolds-cell-constructs requires scaffold materials that can be controlled with regards to their microarchitecture but also chemical and physical properties. A Bio-printer with high resolution permits the spatial control of scaffold materials and also enables the deposition of cells in target areas.

　　Bio-Manufacturing:

　　Usage of smart biomaterials such as cellular components shows high promises to enter a new dimension to address actual unmet medical needs

　　BioInk:

　　Universal Matrix for 3D Tissue Printing. The BioInkTM is a semi-synthetic hydrogel supporting cell growth of different cell types (fibroblasts, keratinocytes, etc.) by providing cell adhesion sites and mimicking the natural extracellular matrix. The BioInkTM is provided as a ready-to-use device to print 3D tissues. Critical parameters such as matrix stiffness, cell adhesion can be tailored. Exclusively designed for BioFactory® and 3DDiscovery® tissue printers.

　　Fluid dispenser:

　　The ALL-IN-ONE Drug discovery liquid handling device. The 3DDiscovery® instrument is a multi-functional liquid handling device responding to today's requirements of 2D/3D Drug Discovery/Toxicology screening applications. The 3DDiscovery® instrument is both a powerful FLUID DISPENSER addressing today's industrial needs, as well as a three-dimensional BIOPRINTER responding to the upcoming challenges facing the pharmaceutical, biotech and clinical research organizations.

生物医药

喜欢作者我要约稿